-
Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Loriere E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA, 2016: Structural basis of potent Zika-dengue virus antibody cross-neutralization[J]. Nature, 536, 48-53. doi: 10.1038/nature18938
-
Dai L, Song J, Lu X, Deng YQ, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, Xiao H, Yan J, Shi Y, Qin CF, Qi J, Gao GF, 2016: Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody[J]. Cell Host Microbe, 19, 696-704. doi: 10.1016/j.chom.2016.04.013
-
Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G, 2010: Cross-reacting antibodies enhance dengue virus infection in humans[J]. Science, 328, 745-748. doi: 10.1126/science.1185181
-
Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR, 2015: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus[J]. Nat Immunol, 16, 170-177. doi: 10.1038/ni.3058
-
Della-Porta AJ, Westaway EG, 1978: A multi-hit model for the neutralization of animal viruses[J]. J Gen Virol, 38, 1-19. doi: 10.1099/0022-1317-38-1-1
-
Deng YQ, Dai JX, Ji GH, Jiang T, Wang HJ, Yang HO, Tan WL, Liu R, Yu M, Ge BX, Zhu QY, Qin ED, Guo YJ, Qin CF, 2011: A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein[J]. PLoS ONE, 6, e16059-. doi: 10.1371/journal.pone.0016059
-
Dowd KA, Pierson TC, 2011: Antibody-mediated neutralization of flaviviruses: a reductionist view[J]. Virology, 411, 306-315. doi: 10.1016/j.virol.2010.12.020
-
Fernandez E, Dejnirattisai W, Cao B, Scheaffer SM, Supasa P, Wongwiwat W, Esakky P, Drury A, Mongkolsapaya J, Moley KH, Mysorekar IU, Screaton GR, Diamond MS, 2017: Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection[J]. Nat Immunol, 18, 1261-1269. doi: 10.1038/ni.3849
-
Fibriansah G, Lok SM, 2016: The development of therapeutic antibodies against dengue virus[J]. Antivir Res, 128, 7-19. doi: 10.1016/j.antiviral.2016.01.002
-
Gerold G, Bruening J, Weigel B, Pietschmann T, 2017: Protein interactions during the flavivirus and hepacivirus life cycle[J]. Mol Cell Proteomics, 16, S75-S91. doi: 10.1074/mcp.R116.065649
-
Harrison SC, 2008: The pH sensor for flavivirus membrane fusion[J]. J Cell Biol, 183, 177-179. doi: 10.1083/jcb.200809175
-
Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE Jr, Kuhn RJ, Rossmann MG, 2017: A human antibody against Zika virus crosslinks the E protein to prevent infection[J]. Nat Commun, 8, 14722-. doi: 10.1038/ncomms14722
-
Hasan SS, Sevvana M, Kuhn RJ, Rossmann MG, 2018: Structural biology of Zika virus and other flaviviruses[J]. Nat Struct Mol Biol, 25, 13-20. doi: 10.1038/s41594-017-0010-8
-
Kostyuchenko VA, Lim EX, Zhang S, Fibriansah G, Ng TS, Ooi JS, Shi J, Lok SM, 2016: Structure of the thermally stable Zika virus[J]. Nature, 533, 425-428. doi: 10.1038/nature17994
-
Li M, Wang X, Wang Q, Yu L, Wang L, Yan J, Zhang F, Zhang L, Gao GF, Jin X, 2017: Both structure and function of human monoclonal antibodies contribute to enhancement of Zika virus infectivity in vitro[J]. Sci China Life Sci, 60, 1396-1398. doi: 10.1007/s11427-017-9192-0
-
Lu LL, Suscovich TJ, Fortune SM, Alter G, 2018: Beyond binding: antibody effector functions in infectious diseases[J]. Nat Rev Immunol, 18, 46-61.
-
Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D, Singh RK, Iqbal HMN, Joshi SK, 2017: Advances in developing therapies to combat Zika virus: current knowledge and future perspectives[J]. Front Microbiol, 8, 1469-. doi: 10.3389/fmicb.2017.01469
-
Perera-Lecoin M, Meertens L, Carnec X, Amara A, 2013: Flavivirus entry receptors: an update[J]. Viruses, 6, 69-88. doi: 10.3390/v6010069
-
Qu P, Zhang W, Li D, Zhang C, Liu Q, Zhang X, Wang X, Dai W, Xu Y, Leng Q, Zhong J, Jin X, Huang Z, 2018: Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection[J]. Antivir Res, 154, 97-103. doi: 10.1016/j.antiviral.2018.04.010
-
Robbiani DF, Bozzacco L, Keeffe JR, Khouri R, Olsen PC, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R, Azzopardi SA, Uhl LFK, Saeed M, Sevilla-Reyes EE, Agudelo M, Yao KH, Golijanin J, Gristick HB, Lee YE, Hurley A, Caskey M, Pai J, Oliveira T, Wunder EA Jr, Sacramento G, Nery N Jr., Orge C, Costa F, Reis MG, Thomas NM, Eisenreich T, Weinberger DM, de Almeida ARP, West AP Jr, Rice CM, Bjorkman PJ, Reyes-Teran G, Ko AI, MacDonald MR, Nussenzweig MC, 2017: Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico[J]. Cell, 169, e511-.
-
Sapparapu G, Fernandez E, Kose N, Bin C, Fox JM, Bombardi RG, Zhao H, Nelson CA, Bryan AL, Barnes T, Davidson E, Mysorekar IU, Fremont DH, Doranz BJ, Diamond MS, Crowe JE, 2016: Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice[J]. Nature, 540, 443-447. doi: 10.1038/nature20564
-
Sevvana M, Long F, Miller AS, Klose T, Buda G, Sun L, Kuhn RJ, Rossmann MG, 2018: Refinement and analysis of the mature Zika virus cryo-EM structure at 3.1?[J]. resolution. Structure, 26, 1169-1177. doi: 10.1016/j.str.2018.05.006
-
Sirohi D, Kuhn RJ, 2017: Zika virus structure, maturation, and receptors[J]. J Infect Dis, 216, S935-S944. doi: 10.1093/infdis/jix515
-
Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, Kuhn RJ, 2016: The 3.8?[J]. resolution cryo-EM structure of Zika virus. Science, 352, 467-470.
-
Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D, 2016: Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection[J]. Science, 353, 823-826. doi: 10.1126/science.aaf8505
-
Stiasny K, Heinz FX, 2006: Flavivirus membrane fusion[J]. J Gen Virol, 87, 2755-2766. doi: 10.1099/vir.0.82210-0
-
Tai W, He L, Wang Y, Sun S, Zhao G, Luo C, Li P, Zhao H, Fremont DH, Li F, Jiang S, Zhou Y, Du L, 2018: Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses[J]. Emerg Microbes Infect, 7, 7-.
-
Wang Q, Yang H, Liu X, Dai L, Ma T, Qi J, Wong G, Peng R, Liu S, Li J, Li S, Song J, Liu J, He J, Yuan H, Xiong Y, Liao Y, Li J, Yang J, Tong Z, Griffin BD, Bi Y, Liang M, Xu X, Qin C, Cheng G, Zhang X, Wang P, Qiu X, Kobinger G, Shi Y, Yan J, Gao GF, 2016: Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus[J]. Sci Transl Med, 8, 369ra179-. doi: 10.1126/scitranslmed.aai8336
-
Wang Q, Yan J, Gao GF, 2017: Monoclonal antibodies against Zika virus: therapeutics and their implications for vaccine design[J]. J Virol, 91, e01049-17.
-
Wu Y, Li S, Du L, Wang C, Zou P, Hong B, Yuan M, Ren X, Tai W, Kong Y, Zhou C, Lu L, Zhou X, Jiang S, Ying T, 2017: Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain Ⅲ[J]. Emerg Microbes Infect, 6, e89-.
-
Zhao H, Fernandez E, Dowd KA, Speer SD, Platt DJ, Gorman MJ, Govero J, Nelson CA, Pierson TC, Diamond MS, Fremont DH, 2016: Structural basis of Zika virus-specific antibody protection[J]. Cell, 166, 1016-1027. doi: 10.1016/j.cell.2016.07.020